Company: DVAX
Filing Date: 2025-04-17
Form Type: DEFC14A
Source: 0000930413-25-001273
Chunk: 97

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-17
Form: DEFC14A
Chunk 97
---
 us from driving innovation.                                                  |

Ethics and Compliance.Our Ethics and Compliance program
includes our Code of Business Conduct and Ethics, which sets forth our expectations of all of our directors, officers and employees globally
that they conduct their business activities in a legal and ethical manner. The Code of Business Conduct and Ethics can be found on our
website under the header “Investors” and, within that, under the header “Corporate Governance and Compliance.”
We have a Chief Ethics and Compliance Officer, a Compliance Steering Committee and policies, procedures and training addressing specific
aspects of our business, including advertising and promotion; engagements with healthcare providers; and regarding our business activities
outside the United States to ensure they comply with the U.S. Foreign Corrupt Practices Act and all other applicable anti-corruption laws.
We certify on an annual basis to having a comprehensive compliance program that meets the standards set forth under California law. This
certification, which sets forth all of the elements of our healthcare compliance program, can be found on our website.

Product Safety and Quality.We have a comprehensive drug
safety and pharmacovigilance system to fulfil our legal responsibilities in relation to pharmacovigilance and which is designed to monitor
the safety of our products to detect any change to their risk-benefit profile. Our drug safety and pharmacovigilance team receive, review
and perform analyses of safety information received globally from a number of sources, including but not limited to, clinical trials,
scientific publications and literature, and post-marketing spontaneous reports to identify any safety trends or signals.

The objective of our product quality system is to ensure consistent,
sustainable production of safe and effective products, while facilitating continuous improvement of our processes and systems. These objectives
are formalized in the Company’s quality manual, which outlines the Company’s commitments to compliance with all applicable
regulatory requirements and safety and quality best practices, including current Good Manufacturing Practices, Good Distribution Practices,
Good Laboratory Practices, Good Pharmacovigilance Practices, and Good Clinical Practices wherever appropriate. Our executive management
has appointed a quality function, led by our Vice President of Quality, with the authority and responsibility for coordinating all aspects
of our quality system and our Vice President of Quality reports directly to our President and Chief Operating Officer. In addition, all
personnel involved in pharmaceutical product development, production and testing participate in training and qualification programs, designed
to ensure that they have the necessary education, training and experience to perform their job functions.

Environmental.We have made, and will